Establishment Labs Holdings Inc. (NASDAQ:ESTA) Stock Holdings Lifted by Cwm LLC

Cwm LLC lifted its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 95.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 146,071 shares of the company’s stock after buying an additional 71,459 shares during the quarter. Cwm LLC owned approximately 0.57% of Establishment Labs worth $3,782,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of ESTA. Baker Avenue Asset Management LP bought a new position in shares of Establishment Labs in the 3rd quarter worth about $59,000. Global Retirement Partners LLC acquired a new stake in shares of Establishment Labs in the 3rd quarter worth about $60,000. Private Trust Co. NA acquired a new stake in shares of Establishment Labs in the 3rd quarter worth about $74,000. Clear Street Markets LLC acquired a new stake in shares of Establishment Labs in the 3rd quarter worth about $88,000. Finally, FNY Investment Advisers LLC acquired a new stake in shares of Establishment Labs in the 4th quarter worth about $93,000. 72.91% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ESTA shares. Mizuho increased their price objective on shares of Establishment Labs from $50.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Citigroup increased their price objective on shares of Establishment Labs from $49.00 to $60.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. JPMorgan Chase & Co. increased their price objective on shares of Establishment Labs from $46.00 to $53.00 and gave the stock an “overweight” rating in a report on Thursday, February 29th. Finally, Stephens reaffirmed an “overweight” rating and issued a $47.00 price objective on shares of Establishment Labs in a report on Thursday, January 11th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Establishment Labs presently has a consensus rating of “Buy” and an average target price of $55.00.

Establishment Labs Stock Performance

Establishment Labs stock opened at $48.95 on Thursday. The company has a debt-to-equity ratio of 10.26, a current ratio of 3.06 and a quick ratio of 1.67. The company’s 50-day moving average price is $47.78 and its two-hundred day moving average price is $36.44. Establishment Labs Holdings Inc. has a 52 week low of $16.96 and a 52 week high of $74.58.

Establishment Labs (NASDAQ:ESTA) last released its earnings results on Wednesday, February 28th. The company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.95) by $0.16. The firm had revenue of $31.60 million for the quarter, compared to analysts’ expectations of $31.44 million. Establishment Labs had a negative net margin of 47.53% and a negative return on equity of 357.81%. Establishment Labs’s quarterly revenue was down 27.9% on a year-over-year basis. During the same quarter last year, the company earned ($0.55) EPS. As a group, analysts expect that Establishment Labs Holdings Inc. will post -1.58 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.